ALLO
ALLO
NASDAQ · Biotechnology

Allogene Therapeutics Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks
$2.28
+0.01 (+0.44%)
As of May 10, 10:25 PM ET ·
Analyst Consensus
Strong Buy
21
Analysts
High
Coverage
Buy 18 86%
Hold 2 10%
Sell 1 5%
Price Target
Analyst Price Target +865.4% upside
Low Target $17.29
Average Target $22.01
High Target $30.07
Current Price $2.28
Current
$2.28
Target
$22.01
$17.29 $22.01 avg $30.07
Scenario Analysis
Bear Case
$17.29
658.3%
Low target
Base Case
$22.01
+865.4%
Avg target
Bull Case
$30.07
+1,218.9%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$4.46
-48.9% from high
52-Week Low
$0.86
+164.5% from low
Target vs 52W High
$22.01
+393.5% vs high
Next Earnings Report
May 13, 2026 · After Market Close
2d
until earnings
EPS Est: $-0.19
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 75% $257.58 +27.8%
AMGN
Amgen Inc
 Hold 44 48% $190.87 -42.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
 Strong Buy 28 96% $143.40 +41.5%